US Stock MarketDetailed Quotes

ANEB Anebulo Pharmaceuticals

Watchlist
  • 1.570
  • -0.120-7.10%
Trading Nov 12 15:07 ET
40.72MMarket Cap-4906P/E (TTM)

Anebulo Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2024
(Q4)Jun 30, 2024
(Q3)Mar 31, 2024
(Q2)Dec 31, 2023
(Q1)Sep 30, 2023
(FY)Jun 30, 2023
(Q4)Jun 30, 2023
(Q3)Mar 31, 2023
(Q2)Dec 31, 2022
(Q1)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
16.44%-8.09M
27.95%-2.05M
31.64%-1.5M
30.49%-1.81M
-34.07%-2.73M
-78.09%-9.68M
-42.52%-2.85M
-49.91%-2.19M
-117.68%-2.61M
-161.46%-2.03M
Net income from continuing operations
30.09%-8.2M
45.91%-1.35M
40.90%-1.65M
28.99%-2.72M
5.02%-2.48M
-71.89%-11.73M
-7.44%-2.5M
-49.11%-2.8M
-256.66%-3.83M
-68.14%-2.61M
Other non cash items
--151.23K
--59.7K
--59.7K
----
----
----
----
----
----
----
Change In working capital
-168.64%-799.26K
-62.82%-939.85K
-114.38%-55.17K
-34.21%652.56K
-224.80%-456.8K
28.28%1.16M
-697.96%-577.23K
32.35%383.79K
550.78%991.91K
-50.63%366.01K
-Change in prepaid assets
-98.53%8.96K
-22.70%-190.11K
-119.59%-51.94K
417.10%355.57K
-124.36%-104.56K
-4.50%608.21K
53.08%-154.95K
4.31%265.11K
-79.64%68.76K
14.40%429.29K
-Change in payables and accrued expense
-245.29%-808.22K
-77.54%-749.74K
-102.73%-3.24K
-67.83%297K
-456.65%-352.24K
105.34%556.27K
-198.95%-422.28K
231.21%118.68K
265.51%923.15K
-117.29%-63.28K
Cash from discontinued investing activities
Operating cash flow
16.44%-8.09M
27.95%-2.05M
31.64%-1.5M
30.49%-1.81M
-34.07%-2.73M
-78.09%-9.68M
-42.52%-2.85M
-49.91%-2.19M
-117.68%-2.61M
-161.46%-2.03M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
-100.98%-62.35K
0
0
74.95%-62.35K
0
6.38M
-68.16K
0
-248.93K
6.7M
Net common stock issuance
--0
--0
--0
--0
--0
--6.65M
--0
--0
--0
--6.65M
Proceeds from stock option exercised by employees
--0
--0
--0
--0
--0
--52.4K
--0
--0
--0
--52.4K
Net other financing activities
80.34%-62.35K
--0
--0
----
----
---317.08K
---68.16K
--0
----
----
Cash from discontinued financing activities
Financing cash flow
-100.98%-62.35K
--0
--0
74.95%-62.35K
--0
--6.38M
---68.16K
--0
---248.93K
--6.7M
Net cash flow
Beginning cash position
-22.69%11.25M
-63.66%5.15M
-59.37%6.64M
-55.65%8.52M
-22.69%11.25M
-27.21%14.55M
-14.40%14.16M
-9.18%16.36M
0.03%19.21M
-27.21%14.55M
Current changes in cash
-146.99%-8.15M
29.63%-2.05M
31.64%-1.5M
34.37%-1.88M
-158.45%-2.73M
39.29%-3.3M
-45.92%-2.92M
-49.91%-2.19M
-138.44%-2.86M
699.72%4.67M
End cash Position
-72.49%3.09M
-72.49%3.09M
-63.66%5.15M
-59.37%6.64M
-55.65%8.52M
-22.69%11.25M
-22.69%11.25M
-14.40%14.16M
-9.18%16.36M
0.03%19.21M
Free cash flow
16.44%-8.09M
27.95%-2.05M
31.64%-1.5M
30.49%-1.81M
-34.07%-2.73M
-78.09%-9.68M
-42.52%-2.85M
-49.91%-2.19M
-117.68%-2.61M
-161.46%-2.03M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Jun 30, 2024(Q4)Jun 30, 2024(Q3)Mar 31, 2024(Q2)Dec 31, 2023(Q1)Sep 30, 2023(FY)Jun 30, 2023(Q4)Jun 30, 2023(Q3)Mar 31, 2023(Q2)Dec 31, 2022(Q1)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 16.44%-8.09M27.95%-2.05M31.64%-1.5M30.49%-1.81M-34.07%-2.73M-78.09%-9.68M-42.52%-2.85M-49.91%-2.19M-117.68%-2.61M-161.46%-2.03M
Net income from continuing operations 30.09%-8.2M45.91%-1.35M40.90%-1.65M28.99%-2.72M5.02%-2.48M-71.89%-11.73M-7.44%-2.5M-49.11%-2.8M-256.66%-3.83M-68.14%-2.61M
Other non cash items --151.23K--59.7K--59.7K----------------------------
Change In working capital -168.64%-799.26K-62.82%-939.85K-114.38%-55.17K-34.21%652.56K-224.80%-456.8K28.28%1.16M-697.96%-577.23K32.35%383.79K550.78%991.91K-50.63%366.01K
-Change in prepaid assets -98.53%8.96K-22.70%-190.11K-119.59%-51.94K417.10%355.57K-124.36%-104.56K-4.50%608.21K53.08%-154.95K4.31%265.11K-79.64%68.76K14.40%429.29K
-Change in payables and accrued expense -245.29%-808.22K-77.54%-749.74K-102.73%-3.24K-67.83%297K-456.65%-352.24K105.34%556.27K-198.95%-422.28K231.21%118.68K265.51%923.15K-117.29%-63.28K
Cash from discontinued investing activities
Operating cash flow 16.44%-8.09M27.95%-2.05M31.64%-1.5M30.49%-1.81M-34.07%-2.73M-78.09%-9.68M-42.52%-2.85M-49.91%-2.19M-117.68%-2.61M-161.46%-2.03M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities -100.98%-62.35K0074.95%-62.35K06.38M-68.16K0-248.93K6.7M
Net common stock issuance --0--0--0--0--0--6.65M--0--0--0--6.65M
Proceeds from stock option exercised by employees --0--0--0--0--0--52.4K--0--0--0--52.4K
Net other financing activities 80.34%-62.35K--0--0-----------317.08K---68.16K--0--------
Cash from discontinued financing activities
Financing cash flow -100.98%-62.35K--0--074.95%-62.35K--0--6.38M---68.16K--0---248.93K--6.7M
Net cash flow
Beginning cash position -22.69%11.25M-63.66%5.15M-59.37%6.64M-55.65%8.52M-22.69%11.25M-27.21%14.55M-14.40%14.16M-9.18%16.36M0.03%19.21M-27.21%14.55M
Current changes in cash -146.99%-8.15M29.63%-2.05M31.64%-1.5M34.37%-1.88M-158.45%-2.73M39.29%-3.3M-45.92%-2.92M-49.91%-2.19M-138.44%-2.86M699.72%4.67M
End cash Position -72.49%3.09M-72.49%3.09M-63.66%5.15M-59.37%6.64M-55.65%8.52M-22.69%11.25M-22.69%11.25M-14.40%14.16M-9.18%16.36M0.03%19.21M
Free cash flow 16.44%-8.09M27.95%-2.05M31.64%-1.5M30.49%-1.81M-34.07%-2.73M-78.09%-9.68M-42.52%-2.85M-49.91%-2.19M-117.68%-2.61M-161.46%-2.03M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data